Arizona State Retirement System Buys 210 Shares of DaVita Inc. (NYSE:DVA)

Arizona State Retirement System grew its holdings in DaVita Inc. (NYSE:DVA) by 1.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,056 shares of the company’s stock after purchasing an additional 210 shares during the period. Arizona State Retirement System’s holdings in DaVita were worth $1,577,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of DVA. Resources Management Corp CT ADV increased its holdings in shares of DaVita by 5,900.0% in the 2nd quarter. Resources Management Corp CT ADV now owns 300 shares of the company’s stock worth $30,000 after purchasing an additional 295 shares in the last quarter. Harbor Investment Advisory LLC purchased a new position in shares of DaVita in the 3rd quarter worth $34,000. Parkside Financial Bank & Trust boosted its stake in shares of DaVita by 88.6% in the 1st quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock worth $35,000 after buying an additional 147 shares during the last quarter. Hanseatic Management Services Inc. purchased a new position in shares of DaVita in the 3rd quarter worth $36,000. Finally, FinTrust Capital Advisors LLC boosted its stake in shares of DaVita by 242.3% in the 3rd quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company’s stock worth $67,000 after buying an additional 504 shares during the last quarter. Institutional investors own 90.12% of the company’s stock.

Insider Buying and Selling at DaVita

In other DaVita news, COO Michael David Staffieri sold 29,488 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $119.81, for a total transaction of $3,532,957.28. Following the sale, the chief operating officer now directly owns 37,687 shares of the company’s stock, valued at $4,515,279.47. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CEO Javier Rodriguez sold 67,603 shares of DaVita stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $126.11, for a total value of $8,525,414.33. Following the sale, the chief executive officer now directly owns 488,697 shares of the company’s stock, valued at $61,629,578.67. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Michael David Staffieri sold 29,488 shares of DaVita stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $119.81, for a total value of $3,532,957.28. Following the completion of the sale, the chief operating officer now directly owns 37,687 shares in the company, valued at $4,515,279.47. The disclosure for this sale can be found here. Insiders have sold a total of 134,540 shares of company stock valued at $16,551,071 over the last ninety days. 1.40% of the stock is currently owned by company insiders.

DaVita Price Performance

NYSE DVA opened at $130.42 on Friday. The company has a market capitalization of $11.44 billion, a PE ratio of 17.62, a price-to-earnings-growth ratio of 1.17 and a beta of 1.04. The company has a debt-to-equity ratio of 6.65, a quick ratio of 1.13 and a current ratio of 1.19. The business’s fifty day moving average is $128.95 and its 200 day moving average is $107.96. DaVita Inc. has a fifty-two week low of $71.51 and a fifty-two week high of $141.54.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, February 13th. The company reported $1.87 EPS for the quarter, beating analysts’ consensus estimates of $1.53 by $0.34. The business had revenue of $3.15 billion for the quarter, compared to analysts’ expectations of $3.01 billion. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period last year, the firm earned $1.11 earnings per share. Sell-side analysts predict that DaVita Inc. will post 9.23 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on DVA. Truist Financial raised their price target on DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a research note on Tuesday, February 20th. TheStreet upgraded DaVita from a “c+” rating to a “b-” rating in a research note on Wednesday, February 7th. StockNews.com upgraded DaVita from a “buy” rating to a “strong-buy” rating in a research note on Monday, April 8th. Barclays assumed coverage on DaVita in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 price target on the stock. Finally, UBS Group lifted their target price on DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, February 14th. Two analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, DaVita presently has a consensus rating of “Moderate Buy” and a consensus target price of $118.50.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.